Management of Diabetes in Pregnancy, Childhood, and Adolescence

Primary Care - Clinics in Office Practice

Volumn 34, Issue 4, 2007, Pages 809-843

  Unger, Jeff ^a  

^a Diabetes and Headache Intervention Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTILIPEMIC AGENT; GLUCOSIDASE; INSULIN; METFORMIN; SULFONYLUREA;

BLOOD GLUCOSE MONITORING; CESAREAN SECTION; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIET THERAPY; DRUG MECHANISM; EXERCISE; FIRST TRIMESTER PREGNANCY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TREATMENT; LABOR INDUCTION; LONG TERM CARE; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREMATURE LABOR; PREVENTION AND CONTROL; PRIORITY JOURNAL; PUERPERIUM; RECURRENT DISEASE; REVIEW; RISK FACTOR; VAGINAL DELIVERY;

ADOLESCENT; AGE FACTORS; CHILD; CHILD WELFARE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HUMANS; INSULIN; PREGNANCY;

EID: 36549063614     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2007.07.008     Document Type: Review

References (77)

1. Reece E.A., and Hobins J.C. Diabetic embryopathy: pathogenesis, prenatal diagnosis, and prevention. Obstet Gynecol Surv 41 (1986) 325-335
2. Hare J.W., and White P. Pregnancy in diabetes complicated by vascular disease. Diabetes 26 (1977) 953-955
3. Miodovnik M., Lavin J.P., Knowles H.C., et al. Spontaneous abortions among insulin-dependent diabetic women. Am J Obstet Gynecol 150 (1984) 372-375
4. Greene M.F. Prevention and diagnosis of congenital anomalies in diabetic pregnancy. Clin Perinatol 20 (1993) 533-547
5. Hanson W., and Persson B. Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregancies in Sweden. Acta Obstet Gynecol Scand 77 (1998) 620-624
6. Kamalakannan D., Baskar V., Barton D.M., et al. Diabetic ketoacidosis in pregnancy. Postgrad Med J 79 (2003) 454-457
7. Coustan D.R., Berkowitz R.L., and Hobbins J.C. Tight metabolic control of overt diabetes in pregnancy. Am J Med 68 (1980) 845-852
8. Cousins L. The California Diabetes and Pregnancy Program: a statewide collaborative program for the preconception and prenatal care of diabetic women. Clin Obstet Gynecol 5 (1991) 443-460
9. Willhoite M.G., Bennert H.W., Palomaki G.E., et al. The impact of preconception counseling on pregnancy outcomes: the experience of the Maine Diabetes in Pregnancy Program. Diabetes Care 16 (1993) 450-455
10. Holing E.V., Beyer C.S., Brown Z.A., et al. Why don't women with diabetes plan their pregnancies?. Diabetes Care 21 (1998) 889-905
11. Unger J. Preconception management of women with type 1 diabetes. Female patient 26 (2001) 40-46
12. Unger J. Assessing glycemic control using home blood glucose monitoring, continuous glucose sensing, and glycated hemoglobin (A1C) testing. In: Unger J. (Ed). Diabetes management in primary care (2007), Lippincott, Williams and Wilkins, Philadelphia 321-362
13. Temple R., Aldridge V., Greenwood R., et al. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ 325 (2002) 1275-1276
14. Hanson U., Persson B., and Thunell S. Relationship between hemoglobin A1C in early type 1 (insulin-dependent) diabetic pregnancies and the occurrence of spontaneous abortions and fetal malformations in Sweden. Diabetologia 33 (1990) 100-104
15. Laatikainen L., Teramo K., Hieta-Heikurainen H., et al. A controlled study of the influence of continuous subcutaneous insulin infusion on diabetic retinopathy during pregnancy. Acta Med Scand 221 (1987) 367-376
16. Unger J. Management of diabetes in pregnancy, childhood, and adolescence. In: Unger J. (Ed). Diabetes management in primary care (2007), Lippincott, Williams and Wilkins, Philadelphia 363-404
17. Diamond T., and Kormas R. Possible adverse fetal effects of insulin lispro. N Engl J Med 337 (1997) 1009
18. Wyatt J.W., Frias J., Hoyme E., et al. Congenital anomaly rate in offspring of women with diabetes treated with Humalog. Diabetologia 46 Suppl 2 (2003) A259
19. Gamson K., Chia S., and Jovanovic L. The safety and efficacy of insulin analogs in pregnancy. J Mat Fetal Neonatal Med 15 (2004) 26-34
20. Ratner R, Bode B, Jovanovic L. Insulin analogs. Presented at the Program of the 11th Annual Meeting of the AACE. Chicago, May 1-5, 2002.
21. Bolli G.B., and Owens D.R. Insulin glargine. Lancet 356 (2000) 443-445
22. Di Cianni G., Volpe L., Lencioni C., et al. Use of insulin glargine during the first weeks of pregnancy in 5 type 1 diabetic women. Diabetes Care 28 (2005) 982-983
23. Challier J.C., Haugel S., and Desmaizieres V. Effects of insulin on glucose uptake and metabolism in the human placenta. J Clin Endocrinol Metab 62 (1986) 803-807
24. Boskovic R., Feig D.S., Derewlany L., et al. Transfer of insulin lispro across the human placenta: in vitro perfusion studies. Diabetes Care 26 (2003) 1390-1394
25. Macones GA, Bader TJ, Asch DA. Optimising maternal-fetal outcomes in preterm labour: a decision analysis. BJOG: An International Journal of Obstetrics and Gynaecology 1998;105(5):541-50.
26. Jovanovic L. Role of diet and insulin treatment of diabetes in pregnancy. Clin Obstet Gynecol 43 (2000) 46-55
27. Harris G.D., and White R.D. Diabetes management and exercise in pregnant patients with diabetes. Clinical Diabetes 23 4 (2005) 165-168
28. Harris G.D. Exercise and the pregnant patient: a clinical overview. Woman Health Primary Care 8 (2005) 79-86
29. Jordan M., and Ripudaman H. Gestational diabetes. Practical Diabetology 24 1 (2005) 6-13
30. Kim C., Newton K.M., and Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes. A systematic review. Diabetes Care 25 (2002) 1862-1868
31. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 27 Suppl 1 (2004) S88-S90
32. Naylor D.C., Phil D., Sermer M., et al. Selective screening for getational diabetes mellitus. N Engl J Med 337 (1997) 1591-1596
33. Turok D.K., Ratcliffe S.D., and Baxley E.G. Screening for gestational diabetes mellitus: recommendation and rationale. Am Fam Physician 68 (2003) 331-335
34. Carpenter M.W., and Coustan D.R. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144 (1982) 768-773
35. Gabbe S.G., Gregory R.P., Power M.L., et al. Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 103 (2004) 1229-1234
36. ACOG Practice Bulletin. Gestational diabetes. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Obstet Gynecol 98 (2001) 525-538
37. Casey B.M., Lucas M.J., Mcintire D.D., et al. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 90 (1997) 869-873
38. Schaefer-Graf U.M., Kjos S.L., Fauzan O.H., et al. A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care 27 (2004) 297-302
39. Walkinshaw S.A. Dietary regulation for "gestational diabetes". Cochrane Database Syst Rev 2 (2003) CD000070
40. Metzger B.E. Summary and recommendations of the Third International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes 40 Suppl 2 (1991) 197-201
41. Artal R., Dorey F.J., and Kirschbaum T.A. Effect of maternal exercise on pregnancy outcome. In: Artal R., Wiswell R.A., and Drinkwater B.L. (Eds). Exercise in pregnancy. 2nd edition (1991), Williams & Wilkins, Baltimore (MD) 225-229
42. Reader D., and Sipe M. Key components of care for women with gestational diabetes. Diabetes Spectrum 14 (2001) 188-191
43. Langer O. When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus. J Matern Fetal Neonatal Med 11 (2002) 218-225
44. Ziegler M.H., Grafton T.F., and Hansen D.K. The effect of tolbutamide on rat embryonic development in vitro. Teratology 48 (1993) 45-51
45. Elliott B.D., Schenker S., Langer O., et al. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol 171 (1994) 653-660
46. Langer O., Conway D.L., Berkus M.D., et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343 (2000) 1134-1138
47. Glueck C.J., Wang P., Goldenberg N., et al. Pregnancy outcomes among women with polycystic ovarian syndrome treated with metformin. Hum Reprod 17 (2002) 2858-2864
48. Fagot-Campagna A., Petitt D.J., Engelgau M.M., et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 136 (2000) 664-672
49. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. Available at: http://www.diabetes.org/uedocuments/NationalDiabetesFactSheetRev.pdf. Accessed October 18, 2007.
50. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 23 (2000) 381-389
51. Krakoff J., Lindsay R.S., Looker H.C., et al. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care 26 (2003) 76-81
52. Banerji M., Chaiken R., Huey H., et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: Flatbush diabetes. Diabetes 43 (1994) 741-745
53. Hegele R.A., Zinman B., Hanley A.J., et al. Genes, environment and Oji-Cree type 2 diabetes. Clin Biochem 36 (2003) 163-170
54. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
55. Kimm S.Y., Glynn N.W., Kriska A.M., et al. Longitudinal changes in physical activity in a biracial cohort during adolescence. Med Sci Sports Exerc 32 (2000) 1445-1454
56. Gungor N., and Arslanian S. Pathophysiology of type 2 diabetes mellitus in children and adolescents: treatment implications. Treat Endocrinol 1 (2002) 359-371
57. Scott R., and Brown L. Rates and causes of mortality in IDDM: a nine year follow-up study. [abstract]. Diabetes 46 Suppl 1 (1997) 146A
58. Lewy V.D., Danadian K., Witchel S.F., et al. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. J Pediatr 138 (2001) 38-44
59. Bhargava S.K., Sachdev H.S., Fall C.H., et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 350 (2004) 865-875
60. Silverman B.L., Metzger B.E., Cho N.H., et al. Impaired glucose tolerance in adolescent offspring of diabetic mothers: relationship to fetal hyperinsulinism. Diabetes Care 18 (1995) 611-617
61. Glowinska B., Urban M., and Koput A. Cardiovascular risk factors in children with obesity, hypertension and diabetes: lipoprotein(a) levels and body mass index correlate with family history of cardiovascular disease. Eur J Pediatr 161 (2002) 511-518
62. Alberti G., Zimmet P., Shaw J., et al., Consensus Workshop Group. Type 2 diabetes in the young: the evolving epidemic. The International Diabetes Federation Consensus Workshop. Diabetes Care 27 (2004) 1798-1811
63. Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287 (2002) 2563-2569
64. Lawson M.L., Gerstein H.C., Tsui E., et al. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes: a systematic review and meta-analysis. Diabetes Care 22 Suppl 2 (1999) B35-B39
65. Cleary P., Orchard T., Zinman B., et al. Coronary calcification in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort. Diabetes 52 Suppl 2 (2003) A152
66. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 25 (2005) 2643-2653
67. Jones K.L., Arslanian S., Peterokova V.A., et al. Effect of metformin in pediatric patients with type 2 diabetes. Diabetes Care 25 (2002) 89-94
68. Zuhri-Yafi M.I., Brosnan P.G., and Hardin D.S. Treatment of type 2 diabetes in children and adolescents. J Pediatr Endocrinol Metab 15 Suppl 1 (2002) 541-546
69. Roldan M.B., Alonso M., and Barrio R. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Diabetes Nutr Metab 12 (1999) 27-31
70. Holmes G.K. Screening for coeliac disease in type 1 diabetes. Arch Dis Child 87 (2002) 495-498
71. Silverstein J., Klingensmith G., Copeland K., et al. Care of children and adolescents with type 1 diabetes. A statement of the American Diabetes Association. Diabetes Care 28 (2005) 186-212
72. Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial: a randomized, controlled trial. Ann Intern Med 128 (1998) 517-523
73. The Diabetes Control and Complications Trial/Epidemiology fo Interventions and Complications Research Group. Retinopathy nephropathy in patients with type 1 diabetes four years after intensive therapy. NEJM 342 (2000) 381-389
74. Allen C., Lecaire T., Palta M., et al. Risk factors for frequent and severe hypoglycemia in type 1 diabetes. Diabetes Care 24 (2001) 1878-1881
75. Maniatis A.K., Klingensmith G.J., Slover R.H., et al. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 107 (2001) 351-356
76. Wilson D.M., Buckingham B.A., Kunselman E.L., et al. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 28 (2005) 15-19
77. Plotnick L.P., Clark L.M., Brancati F.L., et al. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 26 (2003) 1142-1146